is the dosing for bispecific antibodies ongoing until progression or for a set period of time?
Published 1 year ago • 214 plays • Length 4:17Download video MP4
Download video MP3
Similar videos
-
7:40
results of bispecific antibody combination in advanced myeloma | yael cohen, md | asco 2023
-
14:00
what are bispecific antibodies? #myeloma
-
7:34
sequencing bispecific antibodies in myeloma - bcma or gprc5d? | rahul banerjee, md | ims 2024
-
4:55
are there any bispecific antibodies that are fda approved?
-
57:20
know your myeloma immunotherapy: bispecific antibodies with dr. cesar rodriguez
-
3:09
treating rrmm with bispecific antibodies | rakesh popat, phd | eha 2024
-
0:55
what are bispecific antibodies?
-
59:42
alfred garfall, md and bea razzo, md on bispecific antibodies in multiple myeloma
-
27:55
what are the pros and cons of bispecific antibodies for multiple myeloma?
-
1:45
the advent of bispecific antibodies for multiple myeloma
-
3:25
what should myeloma patients know about bispecific antibodies?
-
7:06
efficacy and safety of elranatamab bcma-cd3 bispecific antibody, in patients with rrmm
-
23:13
bispecific antibodies in multiple myeloma | dana-farber cancer institute
-
9:09
regn 5458 - guest lecture #myeloma
-
6:49
an update on the use of bispecific antibodies in myeloma | mohamad mohty, md | ims 2024
-
4:26
what are bispecific antibodies?
-
1:04:03
healthtree podcast for myeloma: peter voorhees, md, levine cancer institute
-
4:35
bispecific antibodies vs car t-cells for r/r multiple myeloma
-
6:35
the benefits of bispecific antibodies for treating multiple myeloma